Add BrightSurf on Google Email

Science News Archive August 2025 - Page 22


Page 22 of 45

Researchers uncover potential mechanism driving treatment resistance in common breast cancer

A study at the Garvan Institute of Medical Research found that inactivation of a stress pathway makes ER+ breast cancer cells ignore stress signals, allowing them to evade treatment. The JNK pathway acts as a cellular alarm system, and its disruption leads to treatment resistance.

SourceGarvan Institute of Medical Research·JournalJournal of Experimental & Clinical Cancer Research·TypeExperimental study·DateAug 18, 2025

Ultrasound could deliver drugs with fewer side effects

Researchers at Stanford Medicine developed a non-invasive system that delivers drugs to specific regions of the body, reducing unwanted side effects. The system uses nanoparticles encapsulated in a sugar solution that responds to ultrasound stimulation, allowing for precise delivery of medication.

SourceStanford Medicine·JournalNature Nanotechnology·TypeExperimental study·DateAug 18, 2025

KIST develops world's first 'high-conductivity amphiphilic MXene' that can be dispersed in a wide range of solvents

Researchers at KIST developed a new surface modification technology to introduce alkoxide organic monomers to MXene, making it both hydrophilic and hydrophobic. This enabled the creation of amphiphilic MXene that can be dispersed in various solvents, including water and non-polar organic solvents.

Ketamine use in chronic pain unsupported by evidence

A new Cochrane review has found no clear evidence of benefit for ketamine in treating chronic pain conditions. The review identified an increased risk of adverse effects such as delusions and vomiting. High-quality trials are needed to determine the role of ketamine in chronic pain care.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateAug 17, 2025

Johns Hopkins University and Utah State University chemists detail new approach to synthetic catalysis for carbon-nitrogen bond formation

A team of international researchers has developed a novel photobiocatalytic approach to create copper-based catalysts that can efficiently form carbon-nitrogen bonds. This breakthrough could lead to the production of life-saving pharmaceuticals in a more sustainable and energy-efficient manner.

SourceUtah State University·JournalScience·TypeExperimental study·DateAug 15, 2025

Students’ image tool offers sharper signs, earlier detection in the lab or from space

A team of UBC Okanagan students developed an adaptive model that can automatically detect subtle shifts in complex images, improving accuracy for doctors and scientists. The technology, called MEBS, uses advanced mathematics to pick out important details, helping to spot illnesses sooner and track wildfires more effectively.

The role of fucosylation in digestive diseases and cancer

The study reveals how genetic mutations in fucosyltransferases contribute to disease susceptibility, leading to inflammatory responses, barrier dysfunction, and increased cancer risk. Aberrant fucosylation is linked to conditions such as liver cirrhosis, hepatocellular carcinoma, pancreatic cancer progression, and gastric cancer.

SourceCompuscript Ltd·JournalGenes & Diseases·DateAug 15, 2025

UBC Okanagan study suggests fasting effects on the body are not the same for everyone

A UBC Okanagan study found that people with obesity may respond differently to fasting compared to lean individuals, especially in their immune systems. While fasting can have health benefits, its effects on metabolism and the immune system are reduced for those living with obesity.

SourceUniversity of British Columbia Okanagan campus·JournaliScience·TypeRandomized controlled/clinical trial·DateAug 15, 2025

ADAMTS2: A multifunctional protein with therapeutic potential

ADAMTS2 plays a pivotal role in collagen maturation and is associated with Ehlers-Danlos syndrome, angiogenesis, lymphangiogenesis, neurodevelopment, immune regulation, and cardiovascular diseases. Its multifunctional nature positions it as a potential therapeutic target for treating genetic disorders, cancer, and cardiovascular diseases.

SourceCompuscript Ltd·JournalGenes & Diseases·DateAug 15, 2025

Researcher from FAPESP-supported center participates in international initiative to improve oxylipin analysis

An international team of researchers established standardized guidelines for analyzing oxylipins, bioactive lipids related to inflammation and disease. The guidelines aim to improve reproducibility in laboratories and facilitate the transfer of scientific discoveries to clinical practice.

Chinese Medical Journal article review explores extracellular vesicles in oocyte health and therapies

Extracellular vesicles play a crucial role in regulating oocyte maturation, follicular growth, and quality. In pathological conditions, EVs can disrupt communication, leading to impaired oocyte development and ovarian failure. Therapeutic EVs show promise in reversing ovarian pathologies by delivering functional molecules.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 15, 2025

Harnessing VR to prevent substance use relapse

George Mason University researchers demonstrate how positive stimuli called recovery cues can lower relapse risk by regulating emotional and physical reactions to triggers. Participants who used personalized VR scenarios showed improved decision-making and reduced cravings for substance use.

SourceGeorge Mason University·JournalFamilies in Society The Journal of Contemporary Social Services·DateAug 15, 2025

Space mice babies

A team of researchers at Kyoto University successfully cryopreserved mouse stem cells and sent them to the International Space Station, where they returned healthy offspring after thawing. The study suggests that cryopreservation can maintain fertility for at least six months, paving the way for future human spaceflight.

SourceKyoto University·JournalStem Cell Reports·TypeExperimental study·DateAug 15, 2025

Children’s Hospital of Philadelphia and Children’s Hospital Colorado researchers conduct first prospective study of pediatric EoE patients and disease progression

A prospective study found that better control of inflammation during childhood leads to less stiffening of the esophagus and fewer disease complications. The study suggests that stiffness of blood vessels in the esophagus could be an important biomarker for disease progression, indicating which patients may benefit from current therapies.

SourceChildren's Hospital of Philadelphia·JournalGastroenterology·TypeObservational study·DateAug 15, 2025

Congress of Neurological Surgeons releases first guidelines on the care of patients with functioning pituitary adenomas

The Congress of Neurological Surgeons has issued its first comprehensive guidelines on the care of adults with functioning pituitary adenomas (FPA), a prevalent and complex condition. The guidelines mark a pivotal step in standardizing care, optimizing patient outcomes, and promoting multidisciplinary coordination.

SourceWolters Kluwer Health·JournalNeurosurgery·DateAug 15, 2025

Scientist uncover hidden immune “hubs” that drive joint damage in rheumatoid arthritis

Researchers found two types of peripheral helper T cells in inflamed joints: stem-like and effector cells. Stem-like cells live in immune hubs and help activate B cells, while effector cells cause inflammation outside the hubs. Targeting stem-like cells may offer new treatment hope for RA patients.

SourceInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University·JournalScience Immunology·TypeExperimental study·DateAug 15, 2025

HKU psychology research reveals how the brain constructs emotional experiences

A recent study by HKU researchers uncovers a brain signature that measures emotional intensity and distinguishes it from automatic physiological responses. This discovery has implications for developing emotionally intelligent AI systems and offers a better understanding of how our brains create emotional arousal.

SourceThe University of Hong Kong·JournalNature Communications·TypeObservational study·DateAug 15, 2025

HKUMed identifies key protein in liver cancer resistance and develops inhibitor to enhance therapy and prevent cancer recurrence

Researchers from HKUMed discovered a previously unknown mechanism that allows HCC to grow more aggressively and evade existing therapies. They developed a new small molecule inhibitor called CL26, which targets the AGPAT4 protein and improves treatment options for HCC patients.

SourceThe University of Hong Kong·JournalScience Translational Medicine·TypeExperimental study·DateAug 15, 2025